6개월 이상 지속되는 복통으로 내원한 18세 남자

키워드

참고문헌 (24)

1. "2020 inflammatory bowel disease fact sheet in Korea" (2020)[URL]
2. Spiller R, "Guidelines on the irritable bowel syndrome : mechanisms and practical management", Gut, 56, pp.1770~1798 (2007)
3. Winter HS, "Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis", J Pediatr, 125, pp.707~711 (1994)
4. Duerr RH, "Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides", diarrheal illnesses, 1991, pp.100, 1590~1596
5. Peeters M, "Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease", Am J Gastroenterol, 96, pp.730~734 (2001)
6. Seibold F, "Neutrophil autoantibodies : a genetic marker in primary sclerosing cholangitis and ulcerative colitis", Gastroenterology, 107, pp.532~536 (1994)
7. Vermeire S, "Comparative study of ASCA (Anti-Saccharomyces cerevisiae antibody) assays in inflammatory bowel disease", Gastroenterology, 120, pp.827~833 (2001)
8. Reumaux D, "Serological markers in inflammatory bowel diseases", Best Pract Res Clin Gastroenterol, 17, pp.19~35 (2003)
9. Damoiseaux JG, "Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease : high prevalence in patients with celiac disease", J Clin Immunol, 22, pp.281~288 (2002)
10. Barclay GR, "The effect of dietary yeast on the activity of stable chronic Crohn's disease", Scand J Gastroenterol, 27, pp.196~200 (1992)
11. Aggio R, "Future methods for the diagnosis of inflammatory bowel disease", Dig Dis, 32, pp.463~467 (2014)
12. Dotan I, "Serologic markers in inflammatory bowel disease : tools for better diagnosis and disease stratification", Expert Rev Gastroenterol Hepatol, 1, pp.265~274 (2007)
13. Schoepfer AM, "Discriminating IBD from IBS : comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies", Inflamm Bowel Dis, 14, pp.32~39 (2008)
14. van Rheenen PF, "Faecal calprotectin for screening of patients with suspected inflammatory bowel disease : diagnostic meta-analysis", BMJ, 341, pp.c3369~ (2010)
15. Schoepfer AM, "Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease(SES-CD)than CRP, blood leukocytes, and the CDAI", Am J Gastroenterol, 105, pp.162~169 (2010)
16. Alfarone L, "Cross-sectional imaging instead of colonoscopy in inflammatory bowel diseases : lights and shadows", J Clin Med, 11, pp.353~ (2022)
17. Panés J, "Systematic review : the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease", Aliment Pharmacol Ther, 34, pp.125~145 (2011)
18. Deepak P, "The role of the radiologist in determining disease severity in inflammatory bowel diseases", Gastrointest Endosc Clin N Am, 29, pp.447~470 (2019)
19. Horsthuis K, "Magnetic resonance imaging for evaluation of disease activity in Crohn's disease : a systematic review", Eur Radiol, 19, pp.1450~1460 (2009)
20. Horsthuis K, "Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT : meta-analysis of prospective studies", Radiology, 247, pp.64~79 (2008)
21. 박종범, "한국인 크론병의 진단시 임상 양상과 경과", 대한소화기학회지, 43(1), pp.8~17 (2004), 대한소화기학회
22. Schroeder KW, "Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study", N Engl J Med, 317, pp.1625~1629 (1987)
23. Langner C, "The histopathological approach to inflammatory bowel disease : a practice guide", Virchows Arch, 464, pp.511~527 (2014)
24. Seldenrijk CA, "Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease : diagnostic implications", Gut, 32, pp.1514~1520 (1991)

관련 논문AI추천